TechValidate Research on Nozin

These pages present data that TechValidate has sourced via direct research with verified customers and users of Nozin. TechValidate stands behind the authenticity of all published data. Learn more »



326 Customers Surveyed

2,339 Data Points Collected

132 Published TechFacts

5 Published Case Studies



Selected Research Highlights


Nozin Case Study

Meritus Health

Introduction

This case study of Meritus Health is based on a September 2019 survey of Nozin customers by TechValidate, a 3rd-party research service.

“Based on initial findings Nasal Decolonization protocols have effectively decreased isolation days while simultaneously cutting isolation costs and improving patient satisfaction.”

Challenges

Meritus Health evaluated and ultimately selected a Nozin infection prevention program to address concerns with the following:

  • Infection prevention
  • Effectiveness of MRSA surveillance
  • Better antibiotic stewardship
  • Operational efficiencies (i.e., patient flow or throughput)
  • Costs

Use Case

Nozin® Nasal Sanitizer® antiseptic is applied to the following populations:

  • ICU patients
  • MRSA colonized patients
  • High risk area patients (history, dialysis, etc)
  • Pre-op patients
  • Post-op patients

Results

Since implementing the Nozin infection prevention program, Meritus Health has achieved the following results:

  • Responsible reduction of MRSA Contact Precautions
  • Less time donning and doffing PPE
  • Increased patient satisfaction
  • Increased staff satisfaction
  • Improved antibiotic stewardship
  • Cost savings
  • Reduced pathogen burden

Nozin Customer Review

5/5 Stars

Implementation was relatively easy considering the scale of a hospital-wide launch.

Nozin Case Study

Holzer Medical Center – Gallipolis

Introduction

This case study of Holzer is based on a January 2019 survey of Nozin customers by TechValidate, a 3rd-party research service.

“Nozin is a pleasant alternative to contact isolation for both patients and staff!”

Challenges

Holzer Medical Center – Gallipolis evaluated and ultimately selected a Nozin infection prevention program to address concerns with the following:

  • Infection prevention
  • Staff and patient satisfaction

Use Case

Nozin® Nasal Sanitizer® antiseptic is applied to the following populations:

  • ICU patients
  • MRSA colonized patients
  • Pre-op patients
  • Post-op patients

Results

Since implementing the Nozin infection prevention program, Holzer Medical Center – Gallipolis has achieved the following results

  • Responsible reduction of MRSA Contact Precautions
  • Less time donning and doffing PPE
  • Increased patient satisfaction
  • Increased staff satisfaction
  • Reduced infections

Nozin Customer Satisfaction Rating

Nozin is effective and easy to use



More to Explore



About Nozin

Global Life Technologies Corp. (GLT) is the maker of Nozin® brand products including Nozin® Nasal Sanitizer® antiseptic and Nozin® Allergy Master® products. Located in Chevy Chase, MD, this U.S. based company follows a mission to improve the quality of life for people by enhancing healthcare with new products based on innovative patented and patent-pending technologies.

Nozin Website   Nozin Website